Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review 31-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review 31

Published:2021-04-14 Issue:17 Volume:178 Page:3359-3372
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Levi‐Schaffer Francesca¹,Marco Ario²^ORCID

Affiliation:

1. Pharmacology & Experimental Therapeutics Unit, School of Pharmacy, Faculty of Medicine, The Institute for Drug Research The Hebrew University of Jerusalem Jerusalem Israel

2. Laboratory for Environmental and Life Sciences University of Nova Gorica Nova Gorica Slovenia

Funder

Ministry of Science and Technology, Israel

Javna Agencija za Raziskovalno Dejavnost RS

Rosetrees Trust

Israel Science Foundation

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15359

Reference116 articles.

1. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID‐19;Accorsi P.;Blood Transfusion,2020

2. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea

3. A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29

4. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

5. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a bispecific Nanobody anti-F17 fimbria as a potential therapeutic tool;Protein Expression and Purification;2024-03

2. Structural and biochemical characteristics of mRNA nanoparticles determine anti–SARS-CoV-2 humoral and cellular immune responses;Science Advances;2022-11-25

3. Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles;Molecular Therapy - Methods & Clinical Development;2022-06

4. Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells;Protein Expression and Purification;2022-06

5. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies;Journal of Immunological Methods;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3